Paid Clinical Trials - 82,000 Members & Growing

  • Paid Clinical Trials
  • About Us
  • Auto-Updates
  • FAQ's
  • Quick Start Guide
www.GlobalTestMarket.com

 

Find Paid Clinical Trials Join Paid Clinical Trials ...

PaidClinicalTrials.org is a registry of compensated and uncompensated, federally and privately supported clinical trials conducted in the United States and around the world. Here you will find information about a trial's purpose, who may participate, locations, and phone numbers.

 

Find Paid Clinical Trials Clinical Trial Seekers - PCT is a public service, sponsor supported, clinical trial database that may be accessed by the general public at no charge in accordance with our terms of service use.

Clinical trials are added and removed each day on a 30 day rotation. For accuracy - We only list clinical trials that have been reported to these government agencies in the last 30 days:

 

U.S. National Library of Medicine,
U.S. Department of Health & Human Services
U.S. National Institutes of health Services.







Paid Clinical Trials - Auto Update Service

If you would like to receive timely and important notifications about new clinical trials in your area please fill out this short form. There is never any cost for our notification services. We value your privacy, your email address and member information is NEVER shared!

*  Your Email Address:
*  Preferred Format:
    Title:
    First Name:
    Country:
    State (US):
    City (UK):
    Territory (AU):

Tips for Finding Clinical Trials

 

One of the toughest and most-time consuming parts for medical research staff conducting the clinical trials is actually finding volunteers willing to participate. Research staff are looking for you! There are numerous ways to identify clinical trials looking for healthy human volunteers.

 

Trials are actively conducted by hospitals, universities, foundations, and contract research organizations (CROs, firms that conduct studies for big pharmaceutical and biotechnology companies). According to CISCRP, nearly 40% of these clinical trials can be learned about through media such as tv, radio, or printed ads. While finding studies through tv and radio ads might be difficult, you can actively scour the wanted section of your local newspapers to find trials.

Most local research clinics run ads for volunteers in the local newspaper, employment papers, on TV, and on the radio. They also post ads on Craigslist and on their own websites. Call them up as soon as you see something of interest. If the study is no longer recruiting volunteers, they might enter you in there database for future study participation.

 

Look up local research clinics in your phone book and ask (a) if they have any studies openly recruiting healthy volunteers and (b) if you could be entered into their volunteer database.

College campuses and major universities with research hospitals are also great places to find clinical trial. Schools of medicine, dentistry, and nursing, along with departments of psychology, sociology, and communications, at local universities, are always looking for willing volunteers for their experiments. Perform an internet search for the hospitals, schools, and departments on nearby campuses, then look for any section concerning clinical trials or research volunteers.


When searching for clinical trials on our website you will click on a Clinical Trial Information sheet like this example. Find Paid Clinical Trials Example Information Sheet. The first thing you should do is to see if the clinical trial is right for you. You can do this by quickly scanning the headings of the information sheet. These headings are highlighted on the left by blue icons as follows:


  >> Status of the Clinical Trial (This will appear at the top in red or green)


Purpose - This will briefly let you know about the clinical trial and how it is conducted.


Eligibility - This tells you age, gender and health status information. If you do not meet these eligibility requirement you should move to another clinical trial.


Contacts and Locations - This will list the locations the clinical trial is being conducted and it will usually list the contact person to call. Note - Even if your location is not listed you should call the clinical trial investigator. Sometimes their locations have not been updated or they are willing to pay time and travel expenses.


More Information - This will often give alternative contact people and other pertinent information about the trial.

These headings appear on the left side of the information sheet and are fairly self explanatory. Doing this will help you to quickly evaluate if the clinical trial is right for you.

 


 

Paid Clinical Trials Searching Tips

 

Paid Clinical Trials Check the Conditions Category - If you only search the "Locations" directory you are missing out on a lot of clinical trials. Trials that are listed by "Condition" usually have multiple locations and can add new locations as the study moves forward.

 

Paid Clinical Trials Register Your Profile with us. - You can post your location and condition in our personal clinical trials directory for FREE. This helps the research recruiters find you when the right trial becomes available. Register for Clinical Trials Here.

 

Paid Clinical Trials Call the Clinical Trial Recruiters - At the bottom of all the information sheets you will see a "Contact Information" heading. Many clinical trials can be conducted in remote locations and the recruiters can help you.

 

Paid Clinical Trials Subscribe to our Auto Update Service - By subscribing to our Auto Update Service you will receive automated emails informing you when new trials have opened in your area.

Sponsored Links







  • Conditions:   Vestibular Schwannoma;   Neurofibromatosis Type 2
    Intervention:   Drug: Endostatin
    Sponsors:   Beijing Tiantan Hospital;   Shandong Simcere-Medgenn Bio-pharmaceutical Co., Ltd
    Recruiting - verified April 2014

  • Condition:   Progressive Supranuclear Palsy
    Interventions:   Other: MIRT and Lokomat;   Other: MIRT
    Sponsor:   Ospedale Generale Di Zona Moriggia-Pelascini
    Recruiting - verified April 2014

  • Condition:   Mild Traumatic Brain Injury
    Interventions:   Device: Active CN-NINM PoNS;   Device: Sham CN-NINM PoNS
    Sponsors:   U.S. Army Medical Research and Materiel Command;   Virginia Commonwealth University;   Department of Veterans Affairs;   The Defense and Veterans Brain Injury Center
    Not yet recruiting - verified April 2014

  • Condition:   Vestibular Neuritis
    Interventions:   Drug: Ginkgo biloba & Methylprednisolone;   Drug: Ginkgo biloba
    Sponsor:   Asan Medical Center
    Recruiting - verified March 2014

  • Conditions:   Chronic Troublesome Sialorrhea Resulting From Neurological Conditions in Adults With Parkinson's Disease or Atypical Parkinsonism (Multiple;   System Atrophy, Corticobasal Degeneration or Progressive Supranuclear Palsy), or After Stroke or Traumatic Brain Injury
    Interventions:   Drug: IncobotulinumtoxinA (100 Units);   Drug: IncobotulinumtoxinA (75 Units);   Drug: Placebo
    Sponsor:   Merz Pharmaceuticals GmbH
    Not yet recruiting - verified March 2014

  • Condition:   Neuromyelitis Optica
    Interventions:   Drug: Alpha1-antitrypsin;   Drug: methylprednisolone
    Sponsor:   Stanford University
    Recruiting - verified March 2014

  • Condition:   Trigeminal Neuralgia
    Intervention:   Biological: Incobotulinumtoxina
    Sponsors:   Thomas Jefferson University;   Merz Pharmaceuticals, LLC
    Recruiting - verified March 2014

  • Condition:   Low Back Pain
    Interventions:   Other: CV4 Cranial (4th ventricle technique) Osteopathic Manipulative;   Other: CV4 (4th ventricle technique) manual therapy sham technique
    Sponsors:   University of Brasilia;   University Hospital of Brasília
    Not yet recruiting - verified March 2014

  • Condition:   Neuromyelitis Optica (NMO) and NMO Spectrum Disorder (NMOSD)
    Intervention:   Drug: SA237
    Sponsor:   Chugai Pharmaceutical
    Not yet recruiting - verified February 2014

  • Condition:   Leber Hereditary Optic Neuropathy
    Intervention:   Genetic: GS010
    Sponsor:   GenSight Biologics
    Recruiting - verified February 2014

  • Conditions:   Alzheimer's Disease (AD);   Chronic Traumatic Encephalopathy (CTE);   Progressive Supranuclear Palsy (PSP);   Frontal Temporal Dementia (FTD);   Pick's Disease;   Tauopathies
    Intervention:   Drug: [18F]T807 ([18F]MNI-777)
    Sponsors:   Molecular NeuroImaging;   Institute for Neurodegenerative Disorders
    Recruiting - verified April 2014

  • Conditions:   Parkinsonian Syndromes;   Parkinson's Disease;   Multiple System Atrophy;   Progressive Supranuclear Palsy
    Interventions:   Other: CSF, blood and urine sampling;   Other: clinical measures of disease severity and progression
    Sponsor:   University Hospital, Bordeaux
    Recruiting - verified April 2014

  • Conditions:   Brain Disorders;   Birth Defects;   Craniofacial Differences
    Intervention:  
    Sponsors:   National Institutes of Health Clinical Center (CC);   National Human Genome Research Institute (NHGRI);   National Eye Institute (NEI);   Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD);   Mount Sinai School of Medicine;   Boston Children's Hospital
    Recruiting - verified December 2013

  • Conditions:   Sporadic Acoustic Neuromas;   Useful Hearing
    Intervention:   Radiation: Radiosurgery
    Sponsor:   Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta
    Recruiting - verified February 2014

  • Conditions:   Non-arteritic Ischemic Optic Neuropathy;   Optic Nerve Injuries
    Interventions:   Drug: RPh201;   Drug: Placebo
    Sponsor:   Regenera Pharma Ltd
    Not yet recruiting - verified January 2014

  • Condition:   Depressive Symptoms
    Intervention:   Device: Trigeminal Nerve Stimulation (TNS)
    Sponsors:   Santa Casa Medical School;   Faculdade de Ciências Médicas da Santa Casa de São Paulo
    Not yet recruiting - verified February 2014

  • Conditions:   Neuromyelitis Optica (NMO);   NMO Spectrum Disorder (NMOSD)
    Intervention:   Drug: SA237
    Sponsor:   Chugai Pharmaceutical
    Recruiting - verified February 2014

  • Conditions:   Acoustic Schwannoma;   Adult Anaplastic Astrocytoma;   Adult Anaplastic Ependymoma;   Adult Anaplastic Meningioma;   Adult Anaplastic Oligodendroglioma;   Adult Brain Stem Glioma;   Adult Choroid Plexus Tumor;   Adult Craniopharyngioma;   Adult Diffuse Astrocytoma;   Adult Ependymoblastoma;   Adult Ependymoma;   Adult Giant Cell Glioblastoma;   Adult Glioblastoma;   Adult Gliosarcoma;   Adult Grade I Meningioma;   Adult Grade II Meningioma;   Adult Medulloblastoma;   Adult Meningeal Hemangiopericytoma;   Adult Mixed Glioma;   Adult Myxopapillary Ependymoma;   Adult Oligodendroglioma;   Adult Papillary Meningioma;   Adult Pilocytic Astrocytoma;   Adult Pineal Gland Astrocytoma;   Adult Pineoblastoma;   Adult Pineocytoma;   Adult Subependymal Giant Cell Astrocytoma;   Adult Subependymoma;   Childhood Choroid Plexus Tumor;   Childhood Craniopharyngioma;   Childhood Ependymoblastoma;   Childhood Grade I Meningioma;   Childhood Grade II Meningioma;   Childhood Grade III Meningioma;   Childhood High-grade Cerebellar Astrocytoma;   Childhood High-grade Cerebral Astrocytoma;   Childhood Infratentorial Ependymoma;   Childhood Low-grade Cerebellar Astrocytoma;   Childhood Low-grade Cerebral Astrocytoma;   Childhood Medulloepithelioma;   Childhood Mixed Glioma;   Childhood Supratentorial Ependymoma;   Meningeal Melanocytoma;   Newly Diagnosed Childhood Ependymoma;   Recurrent Adult Brain Tumor;   Recurrent Childhood Anaplastic Astrocytoma;   Recurrent Childhood Anaplastic Oligoastrocytoma;   Recurrent Childhood Anaplastic Oligodendroglioma;   Recurrent Childhood Brain Stem Glioma;   Recurrent Childhood Cerebellar Astrocytoma;   Recurrent Childhood Cerebral Astrocytoma;   Recurrent Childhood Diffuse Astrocytoma;   Recurrent Childhood Ependymoma;   Recurrent Childhood Fibrillary Astrocytoma;   Recurrent Childhood Gemistocytic Astrocytoma;   Recurrent Childhood Giant Cell Glioblastoma;   Recurrent Childhood Glioblastoma;   Recurrent Childhood Gliomatosis Cerebri;   Recurrent Childhood Gliosarcoma;   Recurrent Childhood Medulloblastoma;   Recurrent Childhood Oligoastrocytoma;   Recurrent Childhood Oligodendroglioma;   Recurrent Childhood Pilocytic Astrocytoma;   Recurrent Childhood Pilomyxoid Astrocytoma;   Recurrent Childhood Pineoblastoma;   Recurrent Childhood Pleomorphic Xanthoastrocytoma;   Recurrent Childhood Protoplasmic Astrocytoma;   Recurrent Childhood Subependymal Giant Cell Astrocytoma;   Recurrent Childhood Supratentorial Primitive Neuroectodermal Tumor;   Recurrent Childhood Visual Pathway and Hypothalamic Glioma;   Recurrent Childhood Visual Pathway Glioma;   Untreated Childhood Anaplastic Astrocytoma;   Untreated Childhood Anaplastic Oligoastrocytoma;   Untreated Childhood Anaplastic Oligodendroglioma;   Untreated Childhood Brain Stem Glioma;   Untreated Childhood Diffuse Astrocytoma;   Untreated Childhood Fibrillary Astrocytoma;   Untreated Childhood Gemistocytic Astrocytoma;   Untreated Childhood Giant Cell Glioblastoma;   Untreated Childhood Glioblastoma;   Untreated Childhood Gliomatosis Cerebri;   Untreated Childhood Gliosarcoma;   Untreated Childhood Medulloblastoma;   Untreated Childhood Oligoastrocytoma;   Untreated Childhood Oligodendroglioma;   Untreated Childhood Pilocytic Astrocytoma;   Untreated Childhood Pilomyxoid Astrocytoma;   Untreated Childhood Pineoblastoma;   Untreated Childhood Pleomorphic Xanthoastrocytoma;   Untreated Childhood Protoplasmic Astrocytoma;   Untreated Childhood Subependymal Giant Cell Astrocytoma;   Untreated Childhood Supratentorial Primitive Neuroectodermal Tumor;   Untreated Childhood Visual Pathway and Hypothalamic Glioma;   Untreated Childhood Visual Pathway Glioma
    Interventions:   Drug: fluorine F 18 fluorodopa;   Procedure: positron emission tomography;   Procedure: computed tomography;   Procedure: diffusion-weighted magnetic resonance imaging;   Procedure: perfusion-weighted magnetic resonance imaging;   Procedure: therapeutic conventional surgery;   Procedure: biopsy;   Other: laboratory biomarker analysis
    Sponsors:   Mayo Clinic;   National Cancer Institute (NCI)
    Recruiting - verified January 2014

  • Conditions:   Non-arteritic Anterior Ischemic Optic Neuropathy;   Decreased Vision Due to Ocular Trauma
    Intervention:   Device: Transcorneal Electrical Stimulation
    Sponsor:   Wills Eye
    Recruiting - verified December 2013

  • Conditions:   Neuromyelitis Optica;   Neuromyelitis Optica Spectrum Disorder
    Intervention:   Biological: eculizumab
    Sponsor:   Alexion Pharmaceuticals
    Not yet recruiting - verified December 2013

  • Conditions:   Childhood Central Nervous System Choriocarcinoma;   Childhood Central Nervous System Germinoma;   Childhood Central Nervous System Mixed Germ Cell Tumor;   Childhood Central Nervous System Teratoma;   Childhood Central Nervous System Yolk Sac Tumor;   Childhood Choroid Plexus Tumor;   Childhood Craniopharyngioma;   Childhood Ependymoblastoma;   Childhood Extracranial Germ Cell Tumor;   Childhood Grade I Meningioma;   Childhood Grade II Meningioma;   Childhood Grade III Meningioma;   Childhood High-grade Cerebellar Astrocytoma;   Childhood High-grade Cerebral Astrocytoma;   Childhood Infratentorial Ependymoma;   Childhood Low-grade Cerebellar Astrocytoma;   Childhood Low-grade Cerebral Astrocytoma;   Childhood Malignant Ovarian Germ Cell Tumor;   Childhood Malignant Testicular Germ Cell Tumor;   Childhood Medulloepithelioma;   Childhood Supratentorial Ependymoma;   Childhood Teratoma;   Recurrent Childhood Anaplastic Astrocytoma;   Recurrent Childhood Anaplastic Oligoastrocytoma;   Recurrent Childhood Anaplastic Oligodendroglioma;   Recurrent Childhood Brain Stem Glioma;   Recurrent Childhood Central Nervous System Embryonal Tumor;   Recurrent Childhood Cerebellar Astrocytoma;   Recurrent Childhood Cerebral Astrocytoma;   Recurrent Childhood Diffuse Astrocytoma;   Recurrent Childhood Ependymoma;   Recurrent Childhood Fibrillary Astrocytoma;   Recurrent Childhood Gemistocytic Astrocytoma;   Recurrent Childhood Giant Cell Glioblastoma;   Recurrent Childhood Glioblastoma;   Recurrent Childhood Gliomatosis Cerebri;   Recurrent Childhood Gliosarcoma;   Recurrent Childhood Malignant Germ Cell Tumor;   Recurrent Childhood Medulloblastoma;   Recurrent Childhood Oligoastrocytoma;   Recurrent Childhood Oligodendroglioma;   Recurrent Childhood Pilocytic Astrocytoma;   Recurrent Childhood Pilomyxoid Astrocytoma;   Recurrent Childhood Pineoblastoma;   Recurrent Childhood Pleomorphic Xanthoastrocytoma;   Recurrent Childhood Protoplasmic Astrocytoma;   Recurrent Childhood Soft Tissue Sarcoma;   Recurrent Childhood Subependymal Giant Cell Astrocytoma;   Recurrent Childhood Supratentorial Primitive Neuroectodermal Tumor;   Recurrent Childhood Visual Pathway and Hypothalamic Glioma;   Recurrent Childhood Visual Pathway Glioma;   Recurrent Neuroblastoma;   Recurrent Osteosarcoma;   Recurrent Retinoblastoma;   Recurrent Wilms Tumor and Other Childhood Kidney Tumors;   Recurrent/Refractory Childhood Hodgkin Lymphoma;   Unspecified Childhood Solid Tumor, Protocol Specific
    Interventions:   Drug: etoposide;   Drug: ifosfamide;   Drug: carboplatin;   Drug: topotecan hydrochloride;   Drug: vincristine sulfate;   Drug: cyclophosphamide;   Drug: cisplatin;   Biological: filgrastim;   Other: laboratory biomarker analysis
    Sponsors:   Barbara Ann Karmanos Cancer Institute;   National Cancer Institute (NCI);   Children's Hospital of Michigan
    Recruiting - verified November 2013

  • Conditions:   Brain Metastasis;   Spinal Tumors;   Lung Tumors;   Ependymoma
    Intervention:   Radiation: SBRT treatment
    Sponsor:   Centre Leon Berard
    Recruiting - verified December 2013

  • Condition:   Optic Neuritis
    Intervention:   Drug: ACTHAR
    Sponsors:   Neuro-Ophthalmologic Associates, PC;   Questcor Pharmaceuticals, Inc.
    Recruiting - verified November 2013

  • Condition:   Parkinson's Disease
    Intervention:   Other: biweekly treatment intervention
    Sponsor:   Zia, Al Raza
    Recruiting - verified November 2013

  • Condition:   Optic Neuritis
    Interventions:   Drug: Erythropoietin;   Drug: Placebo
    Sponsor:   University Eye Hospital, Freiburg
    Not yet recruiting - verified October 2013

  • Condition:   Alzheimer Disease
    Intervention:   Device: rTMS real
    Sponsor:   Lawson Health Research Institute
    Recruiting - verified March 2014

  • Conditions:   Hydrocephalus;   Intracranial Hypertension
    Interventions:   Procedure: Ultrasound guided ventricular drain insertion;   Procedure: landmark-based ventricular drain insertion
    Sponsor:   University Hospital Inselspital, Berne
    Not yet recruiting - verified October 2013

  • Conditions:   Cranial Nerve Diseases;   Facial Neuralgia;   Trigeminal Neuralgia;   Hemifacial Spasm
    Interventions:   Procedure: prophylactic spinal tap;   Procedure: no prophylactic spinal tap
    Sponsors:   St. Olavs Hospital;   Norwegian University of Science and Technology;   Karolinska University Hospital;   University Hospital of North Norway
    Recruiting - verified February 2014

  • Condition:   Vestibular Schwannoma
    Intervention:   Radiation: Initial Gamma knife radiosurgery
    Sponsor:   Karolinska Institutet
    Recruiting - verified March 2014

  • Conditions:   Neuromyelitis Optica;   Neuromyelitis Optica Spectrum Disorders
    Intervention:   Drug: Mitoxantrone
    Sponsor:   Xuanwu Hospital, Beijing
    Recruiting - verified December 2013

  • Conditions:   Retinal Disease;   Macular Degeneration;   Hereditary Retinal Dystrophy;   Optic Nerve Disease;   Glaucoma
    Interventions:   Procedure: RB (Retrobulbar);   Procedure: ST (Subtenon);   Procedure: IV (Intravenous);   Procedure: IVIT (Intravitreal);   Procedure: IO (Intraocular)
    Sponsors:   Retina Associates of South Florida;   MD Stem Cells
    Recruiting - verified March 2014

  • Condition:   Non Arteritic Ischemic Optic Neuropathy
    Interventions:   Drug: dalfampridine;   Drug: Placebo
    Sponsors:   Neuro-Ophthalmologic Associates, PC;   Acorda Therapeutics
    Recruiting - verified October 2013

  • Condition:   Recurrent Vestibulopathy
    Interventions:   Drug: Renexin;   Drug: Placebo
    Sponsors:   Asan Medical Center;   Jong Woo Chung;   SK Chemicals Co.,Ltd.
    Recruiting - verified September 2013

  • Conditions:   Developmental Cochlear Nerve Deficiency;   Acquired Cochlear Nerve Deficiency;   Cochlear Aplasia;   Post-meningitis Cochlear Ossification;   Cochlear Malformation
    Intervention:   Device: Auditory Brainstem Implantation in Children
    Sponsor:   University of North Carolina, Chapel Hill
    Recruiting - verified April 2014

  • Conditions:   Inhalational Anesthetics Adverse Reaction;   Delirium on Emergence;   Strabismus Following Ocular Surgery
    Interventions:   Drug: Dexmedetomidine;   Drug: Midazolam;   Drug: Saline
    Sponsors:   Fujian Provincial Hospital;   Yao Yusheng;   West China Hospital
    Recruiting - verified May 2013

  • Condition:   Leber Hereditary Optic Neuropathy (LHON)
    Intervention:  
    Sponsors:   Santhera Pharmaceuticals;   European Vision Clinical Research (EVICR) Network
    Not yet recruiting - verified July 2013

  • Conditions:   Neuromyelitis Optica;   Neuromyelitis Optica Spectrum Disorder
    Intervention:   Drug: Eculizumab
    Sponsor:   Alexion Pharmaceuticals
    Recruiting - verified March 2014

  • Condition:   Acute Autoimmune Optic Neuritis
    Interventions:   Drug: Amiloride hydrochlorothiazide;   Drug: Sugar pill
    Sponsor:   Medical University of Vienna
    Not yet recruiting - verified June 2013

  • Conditions:   Neurofibromatosis Type 2;   Vestibular Schwannomas;   Meningiomas
    Intervention:   Drug: RAD001 10mg p.o. daily
    Sponsor:   New York University School of Medicine
    Recruiting - verified June 2013

  • Condition:   Third Division of Fifth Cranial Nerve Disorder
    Intervention:  
    Sponsor:   Chang Gung Memorial Hospital
    Not yet recruiting - verified February 2013

  • Condition:   Primary Lung Tuberculosis
    Intervention:  
    Sponsor:   Yonsei University
    Not yet recruiting - verified May 2013

  • Conditions:   Opsoclonus Myoclonus Syndrome;   Neuroblastoma
    Interventions:   Drug: Dexamethasone acetate;   Drug: dexamethasone and cyclophosphamide;   Drug: dexamethasone and rituximab
    Sponsor:   Institut Curie
    Recruiting - verified March 2014

  • Conditions:   Neurofibromatosis 1;   Neurofibromatosis 2;   Schwannomatosis
    Intervention:  
    Sponsor:   The Children's Tumor Foundation
    Recruiting - verified June 2013

  • Condition:   Multiple Sclerosis
    Intervention:  
    Sponsors:   National Institutes of Health Clinical Center (CC);   National Institute of Neurological Disorders and Stroke (NINDS);   National Eye Institute (NEI)
    Recruiting - verified February 2014

  • Condition:   Neuromyelitis Optica Spectrum Disorder
    Intervention:   Drug: NPB-01
    Sponsor:   Nihon Pharmaceutical Co., Ltd
    Recruiting - verified July 2013

  • Condition:   Multiple Sclerosis
    Interventions:   Drug: ACTHAR Gel (ACTH);   Drug: IV steroids with oral taper
    Sponsors:   University of Texas Southwestern Medical Center;   Elliot Frohman;   University of Colorado, Denver;   Questcor Pharmaceuticals, Inc.
    Recruiting - verified March 2014

  • Conditions:   Strabismus;   Delirium on Emergence;   Pediatric Disorders
    Interventions:   Drug: Dexmedetomidine;   Other: Placebo
    Sponsor:   New York University School of Medicine
    Recruiting - verified March 2014

  • Conditions:   Pilomyxoid Astrocytoma;   Pilocytic Astrocytoma;   Glioma, Astrocytic;   Optic Nerve Glioma;   Pleomorphic Xanthoastrocytoma
    Interventions:   Drug: Mebendazole;   Drug: Vincristine;   Drug: Carboplatin;   Drug: Temozolomide
    Sponsors:   North Shore Long Island Jewish Health System;   Mark Atlas
    Not yet recruiting - verified April 2013

  • Conditions:   Cataract;   Retinal Edema;   Inflammation
    Interventions:   Drug: Prolensa (bromfenac 0.07%);   Drug: Ilevro (nepafenac 0.3%)
    Sponsors:   Discover Vision Centers;   Melissa Toyos, MD;   Bausch & Lomb Incorporated
    Recruiting - verified April 2014

  • Condition:   Strabismus
    Interventions:   Drug: subtenons anesthetic - preservative-free bupivacaine 0.75%;   Drug: topical anesthetic - 0.5 cc of lidocaine 3.5% ophthalmic gel;   Drug: topical control - 0.5 cc of Hypromellose 0.3% gel;   Drug: subtenons control - 0.5 cc of Normal Saline
    Sponsor:   Duke University
    Recruiting - verified October 2013

  • Condition:   Traumatic Optic Neuropathy
    Intervention:   Drug: Recombinant human erythropoietin (EPO)
    Sponsors:   Tehran University of Medical Sciences;   Iran University of Medical Sciences;   Mashhad University of Medical Sciences;   Shahid Beheshti Medical University
    Recruiting - verified March 2014

  • Conditions:   Neuromyelitis Optica;   Neuromyelitis Optica Spectrum Disorder
    Intervention:   Drug: Bevacizumab
    Sponsors:   Johns Hopkins University;   Genentech;   Guthy Jackson Charitable Foundation
    Recruiting - verified January 2014

  • Conditions:   Progressive Supranuclear Palsy;   Corticobasal Degeneration
    Intervention:   Other: Observational Study
    Sponsors:   University of California, San Francisco;   National Institutes of Health (NIH);   National Institute on Aging (NIA)
    Recruiting - verified April 2014

  • Conditions:   Parkinson's Disease (PD);   Parkinsonism;   Progressive Supranuclear Palsy (PSP);   Multiple System Atrophy (MSA)
    Intervention:  
    Sponsor:   Milton S. Hershey Medical Center
    Recruiting - verified October 2013

  • Condition:   Anterior Ischemic Optic Neuropathy
    Interventions:   Device: Enhanced external counterpulsation;   Drug: Aspirin
    Sponsor:   First Affiliated Hospital, Sun Yat-Sen University
    Recruiting - verified August 2013

  • Conditions:   Neurofibromatosis Type 2;   Progressive Vestibular Schwannomas
    Intervention:   Drug: Bevacizumab
    Sponsors:   University of Alabama at Birmingham;   Genentech
    Recruiting - verified May 2013

  • Condition:   Acute Demylelinating Optic Neuritis
    Interventions:   Drug: Fingolimod 0.5mg/daily;   Drug: Placebo
    Sponsors:   Novartis;   Novartis Pharmaceuticals
    Recruiting - verified January 2014

  • Condition:   Acute Optic Neuritis
    Intervention:   Biological: BIIB033
    Sponsors:   Biogen Idec;   Biogen Idec Australia Pty Ltd;   Biogen Idec Research Ltd.;   Biogen Idec MA Inc.
    Recruiting - verified November 2013

  • Condition:   Multiple Sclerosis
    Interventions:   Drug: Verum arm receiving Gilenya®;   Drug: Active Comparator receiving Extavia®
    Sponsors:   Charite University, Berlin, Germany;   NeuroCure
    Recruiting - verified February 2014

  • Conditions:   Adult Nasal Type Extranodal NK/T-cell Lymphoma;   Anaplastic Large Cell Lymphoma;   Angioimmunoblastic T-cell Lymphoma;   B-cell Adult Acute Lymphoblastic Leukemia;   B-cell Chronic Lymphocytic Leukemia;   Cutaneous B-cell Non-Hodgkin Lymphoma;   Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue;   Hepatic Complications;   Hepatosplenic T-cell Lymphoma;   Intraocular Lymphoma;   Male Breast Cancer;   Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma;   Nodal Marginal Zone B-cell Lymphoma;   Noncutaneous Extranodal Lymphoma;   Peripheral T-cell Lymphoma;   Recurrent Adenoid Cystic Carcinoma of the Oral Cavity;   Recurrent Adult Acute Lymphoblastic Leukemia;   Recurrent Adult Burkitt Lymphoma;   Recurrent Adult Diffuse Large Cell Lymphoma;   Recurrent Adult Diffuse Mixed Cell Lymphoma;   Recurrent Adult Diffuse Small Cleaved Cell Lymphoma;   Recurrent Adult Grade III Lymphomatoid Granulomatosis;   Recurrent Adult Hodgkin Lymphoma;   Recurrent Adult Immunoblastic Large Cell Lymphoma;   Recurrent Adult Lymphoblastic Lymphoma;   Recurrent Adult T-cell Leukemia/Lymphoma;   Recurrent Basal Cell Carcinoma of the Lip;   Recurrent Bladder Cancer;   Recurrent Breast Cancer;   Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma;   Recurrent Esthesioneuroblastoma of the Paranasal Sinus and Nasal Cavity;   Recurrent Grade 1 Follicular Lymphoma;   Recurrent Grade 2 Follicular Lymphoma;   Recurrent Grade 3 Follicular Lymphoma;   Recurrent Inverted Papilloma of the Paranasal Sinus and Nasal Cavity;   Recurrent Lymphoepithelioma of the Nasopharynx;   Recurrent Lymphoepithelioma of the Oropharynx;   Recurrent Mantle Cell Lymphoma;   Recurrent Marginal Zone Lymphoma;   Recurrent Melanoma;   Recurrent Metastatic Squamous Neck Cancer With Occult Primary;   Recurrent Midline Lethal Granuloma of the Paranasal Sinus and Nasal Cavity;   Recurrent Mucoepidermoid Carcinoma of the Oral Cavity;   Recurrent Mycosis Fungoides/Sezary Syndrome;   Recurrent Pancreatic Cancer;   Recurrent Salivary Gland Cancer;   Recurrent Small Lymphocytic Lymphoma;   Recurrent Squamous Cell Carcinoma of the Hypopharynx;   Recurrent Squamous Cell Carcinoma of the Larynx;   Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity;   Recurrent Squamous Cell Carcinoma of the Nasopharynx;   Recurrent Squamous Cell Carcinoma of the Oropharynx;   Recurrent Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity;   Recurrent Verrucous Carcinoma of the Larynx;   Recurrent Verrucous Carcinoma of the Oral Cavity;   Refractory Chronic Lymphocytic Leukemia;   Refractory Hairy Cell Leukemia;   Small Intestine Lymphoma;   Splenic Marginal Zone Lymphoma;   Stage III Adenoid Cystic Carcinoma of the Oral Cavity;   Stage III Basal Cell Carcinoma of the Lip;   Stage III Bladder Cancer;   Stage III Esthesioneuroblastoma of the Paranasal Sinus and Nasal Cavity;   Stage III Inverted Papilloma of the Paranasal Sinus and Nasal Cavity;   Stage III Lymphoepithelioma of the Nasopharynx;   Stage III Lymphoepithelioma of the Oropharynx;   Stage III Midline Lethal Granuloma of the Paranasal Sinus and Nasal Cavity;   Stage III Mucoepidermoid Carcinoma of the Oral Cavity;   Stage III Pancreatic Cancer;   Stage III Salivary Gland Cancer;   Stage III Squamous Cell Carcinoma of the Hypopharynx;   Stage III Squamous Cell Carcinoma of the Larynx;   Stage III Squamous Cell Carcinoma of the Lip and Oral Cavity;   Stage III Squamous Cell Carcinoma of the Nasopharynx;   Stage III Squamous Cell Carcinoma of the Oropharynx;   Stage III Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity;   Stage III Verrucous Carcinoma of the Larynx;   Stage III Verrucous Carcinoma of the Oral Cavity;   Stage IIIA Breast Cancer;   Stage IIIA Melanoma;   Stage IIIB Breast Cancer;   Stage IIIB Melanoma;   Stage IIIC Breast Cancer;   Stage IIIC Melanoma;   Stage IV Bladder Cancer;   Stage IV Breast Cancer;   Stage IV Lymphoepithelioma of the Nasopharynx;   Stage IV Melanoma;   Stage IV Pancreatic Cancer;   Stage IV Squamous Cell Carcinoma of the Hypopharynx;   Stage IV Squamous Cell Carcinoma of the Nasopharynx;   Stage IVA Adenoid Cystic Carcinoma of the Oral Cavity;   Stage IVA Basal Cell Carcinoma of the Lip;   Stage IVA Esthesioneuroblastoma of the Paranasal Sinus and Nasal Cavity;   Stage IVA Inverted Papilloma of the Paranasal Sinus and Nasal Cavity;   Stage IVA Lymphoepithelioma of the Oropharynx;   Stage IVA Midline Lethal Granuloma of the Paranasal Sinus and Nasal Cavity;   Stage IVA Mucoepidermoid Carcinoma of the Oral Cavity;   Stage IVA Salivary Gland Cancer;   Stage IVA Squamous Cell Carcinoma of the Larynx;   Stage IVA Squamous Cell Carcinoma of the Lip and Oral Cavity;   Stage IVA Squamous Cell Carcinoma of the Oropharynx;   Stage IVA Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity;   Stage IVA Verrucous Carcinoma of the Larynx;   Stage IVA Verrucous Carcinoma of the Oral Cavity;   Stage IVB Adenoid Cystic Carcinoma of the Oral Cavity;   Stage IVB Basal Cell Carcinoma of the Lip;   Stage IVB Esthesioneuroblastoma of the Paranasal Sinus and Nasal Cavity;   Stage IVB Inverted Papilloma of the Paranasal Sinus and Nasal Cavity;   Stage IVB Lymphoepithelioma of the Oropharynx;   Stage IVB Midline Lethal Granuloma of the Paranasal Sinus and Nasal Cavity;   Stage IVB Mucoepidermoid Carcinoma of the Oral Cavity;   Stage IVB Salivary Gland Cancer;   Stage IVB Squamous Cell Carcinoma of the Larynx;   Stage IVB Squamous Cell Carcinoma of the Lip and Oral Cavity;   Stage IVB Squamous Cell Carcinoma of the Oropharynx;   Stage IVB Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity;   Stage IVB Verrucous Carcinoma of the Larynx;   Stage IVB Verrucous Carcinoma of the Oral Cavity;   Stage IVC Adenoid Cystic Carcinoma of the Oral Cavity;   Stage IVC Basal Cell Carcinoma of the Lip;   Stage IVC Esthesioneuroblastoma of the Paranasal Sinus and Nasal Cavity;   Stage IVC Inverted Papilloma of the Paranasal Sinus and Nasal Cavity;   Stage IVC Lymphoepithelioma of the Oropharynx;   Stage IVC Midline Lethal Granuloma of the Paranasal Sinus and Nasal Cavity;   Stage IVC Mucoepidermoid Carcinoma of the Oral Cavity;   Stage IVC Salivary Gland Cancer;   Stage IVC Squamous Cell Carcinoma of the Larynx;   Stage IVC Squamous Cell Carcinoma of the Lip and Oral Cavity;   Stage IVC Squamous Cell Carcinoma of the Oropharynx;   Stage IVC Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity;   Stage IVC Verrucous Carcinoma of the Larynx;   Stage IVC Verrucous Carcinoma of the Oral Cavity;   T-cell Adult Acute Lymphoblastic Leukemia;   T-cell Large Granular Lymphocyte Leukemia;   Testicular Lymphoma;   Tongue Cancer;   Unspecified Adult Solid Tumor, Protocol Specific;   Waldenström Macroglobulinemia
    Interventions:   Drug: romidepsin;   Other: pharmacological study
    Sponsor:   National Cancer Institute (NCI)
    Recruiting - verified March 2014

  • Conditions:   Neuromyelitis Optica;   Neuromyelitis Optica Spectrum Disorder;   Transverse Myelitis;   Optic Neuritis
    Intervention:  
    Sponsor:   University of Texas Southwestern Medical Center
    Recruiting - verified September 2013

  • Condition:   Facial Bones Fracture
    Intervention:   Drug: Ramosetron
    Sponsor:   Seoul National University Hospital
    Recruiting - verified April 2014

  • Conditions:   Guillain-Barré Syndrome;   Miller Fisher Syndrome
    Intervention:  
    Sponsor:   Erasmus Medical Center
    Recruiting - verified November 2013

  • Conditions:   Neurofibromatosis Type 1;   Recurrent Childhood Pilocytic Astrocytoma;   Recurrent Childhood Visual Pathway Glioma
    Intervention:   Drug: lenalidomide
    Sponsor:   National Cancer Institute (NCI)
    Recruiting - verified December 2013

  • Conditions:   Movement Disorders (Incl Parkinsonism);   Tremor Familial Essential, 1;   REM Sleep Behavior Disorder
    Intervention:  
    Sponsor:   University of Alabama at Birmingham
    Recruiting - verified January 2014

  • Condition:   Convergence Insufficiency
    Interventions:   Other: Active home-based computer vergence/accommodative therapy;   Procedure: Near target push-ups;   Other: Placebo home-based computer vergence/accommodative therapy;   Procedure: Placebo yoked prism flippers
    Sponsors:   Jaeb Center for Health Research;   National Eye Institute (NEI)
    Recruiting - verified March 2014

  • Conditions:   Neuromyelitis Optica;   Neuromyelitis Optica Spectrum Disorder;   Recurrent Idiopathic Longitudinally Extensive Transverse Myelitis
    Intervention:   Procedure: Plasma exchange (PLEX)
    Sponsors:   Mayo Clinic;   Terumo BCT
    Recruiting - verified January 2014

  • Conditions:   Optic Neuritis;   Multiple Sclerosis
    Interventions:   Drug: Phenytoin;   Drug: Placebo
    Sponsors:   University College, London;   National Multiple Sclerosis Society;   Multiple Sclerosis Society of Great Britain and Northern Ireland
    Recruiting - verified December 2013

  • Conditions:   Optic Glioma;   Pilocytic Astrocytoma;   Low Grade Glioma;   Fibriullary Astrocytoma
    Intervention:   Drug: AZD6244
    Sponsors:   National Institutes of Health Clinical Center (CC);   National Cancer Institute (NCI)
    Recruiting - verified November 2013

  • Condition:   Brain Injury
    Intervention:   Drug: 1: Sevoflurane
    Sponsors:   Assistance Publique - Hôpitaux de Paris;   Ministry of Health, France
    Recruiting - verified December 2012

  • Conditions:   Retinal Diseases;   Optic Nerve Diseases
    Interventions:   Other: Observational: to better characterize the retina and optic nerve in newborns using spectral domain optical coherence tomography (s-oct).;   Procedure: OCT imaging.
    Sponsors:   University of California, Los Angeles;   Los Angeles Biomedical Research Institute
    Recruiting - verified December 2013

  • Conditions:   Multiple Sclerosis;   Optic Neuritis
    Intervention:   Drug: Mangafodipir (Teslascan)
    Sponsors:   National Institutes of Health Clinical Center (CC);   National Institute of Neurological Disorders and Stroke (NINDS)
    Recruiting - verified August 2013

  • Condition:   Leber Hereditary Optic Neuropathy
    Intervention:   Drug: rAAV2-ND4
    Sponsors:   Huazhong University of Science and Technology;   Bin Li
    Recruiting - verified September 2013

  • Conditions:   Brain Tumor;   Head and Neck Tumor;   Skull Base Tumor
    Intervention:   Procedure: PET scan
    Sponsors:   Massachusetts General Hospital;   National Cancer Institute (NCI)
    Recruiting - verified April 2014

  • Conditions:   Vestibular Schwannoma;   Acoustic Neuroma
    Intervention:   Radiation: Fractionated proton radiation
    Sponsors:   Massachusetts General Hospital;   National Cancer Institute (NCI)
    Recruiting - verified April 2014

  • Condition:   Esotropia
    Interventions:   Procedure: mVEP Testing;   Procedure: Stereoacuity Testing;   Procedure: Optokinetic nystagmus testing;   Procedure: Motion detection testing;   Procedure: Motion discrimination testing
    Sponsor:   The Hospital for Sick Children
    Recruiting - verified August 2013

  • Condition:   Alzheimer's Disease
    Intervention:   Device: TMS, H coil
    Sponsor:   Brainsway
    Recruiting - verified July 2011

  • Conditions:   Vertigo;   Headache;   Anomaly of Vergence System;   Accommodation Disorders;   Orthoptic Rehabilitation
    Interventions:   Procedure: orthoptic rehabilitation;   Other: Orthoptic diagnostic
    Sponsors:   Assistance Publique - Hôpitaux de Paris;   France: Centre National de la Recherche Scientifique
    Recruiting - verified August 2013

  • Condition:   Nonarteritic Anterior Ischemic Optic Neuropathy
    Intervention:   Drug: PDE5 Inhibitors
    Sponsor:   Eli Lilly and Company
    Recruiting - verified March 2014

  • Conditions:   Childhood Low-grade Cerebellar Astrocytoma;   Childhood Low-grade Cerebral Astrocytoma;   Childhood Mixed Glioma;   Childhood Pilocytic Astrocytoma;   Neurofibromatosis Type 1;   Recurrent Childhood Anaplastic Oligodendroglioma;   Recurrent Childhood Brain Stem Glioma;   Recurrent Childhood Cerebellar Astrocytoma;   Recurrent Childhood Cerebral Astrocytoma;   Recurrent Childhood Oligodendroglioma;   Recurrent Childhood Pilocytic Astrocytoma;   Recurrent Childhood Visual Pathway and Hypothalamic Glioma;   Recurrent Childhood Visual Pathway Glioma
    Interventions:   Drug: selumetinib;   Other: laboratory biomarker analysis;   Other: pharmacological study;   Other: pharmacogenomic studies
    Sponsor:   National Cancer Institute (NCI)
    Recruiting - verified November 2013

  • Conditions:   Neurofibromatosis Type 1;   Malignant Peripheral Nerve Sheath Tumor;   Plexiform Neurofibroma;   Optic Glioma;   Neurofibroma
    Intervention:  
    Sponsors:   National Institutes of Health Clinical Center (CC);   National Cancer Institute (NCI)
    Recruiting - verified May 2013

  • Condition:   Anterior Ischemic Optic Neuropathy
    Intervention:   Drug: Diagnostic procedures
    Sponsor:   Bayer
    Recruiting - verified April 2014

  • Conditions:   Vestibular Schwannoma;   NF2;   Neurofibromatosis 2;   Acoustic Neuroma;   Auditory Tumor
    Intervention:   Drug: lapatinib
    Sponsors:   Sidney Kimmel Comprehensive Cancer Center;   The Children's Tumor Foundation;   GlaxoSmithKline;   New York University;   Ohio State University;   House Research Institute;   Washington University School of Medicine;   Weill Medical College of Cornell University;   Massachusetts General Hospital
    Recruiting - verified August 2013

  • Conditions:   Albinism;   Oculocutaneous Albinism;   Foveal Hypoplasia;   Hypopigmentation;   Nystagmus
    Intervention:  
    Sponsors:   National Institutes of Health Clinical Center (CC);   National Human Genome Research Institute (NHGRI)
    Recruiting - verified March 2014

  • Condition:   Opsoclonus-myoclonus Syndrome
    Intervention:  
    Sponsor:   National Pediatric Myoclonus Center
    Recruiting - verified January 2014

  • Condition:   Devic's Disease
    Intervention:   Procedure: Hematopoietic stem cell transplantation
    Sponsor:   Northwestern University
    Recruiting - verified February 2014

  • Conditions:   Childhood Germ Cell Tumor;   Extragonadal Germ Cell Tumor;   Gastrointestinal Complications;   Infertility;   Long-term Effects Secondary to Cancer Therapy in Children;   Neurotoxicity;   Ovarian Cancer;   Pulmonary Complications;   Sexual Dysfunction;   Urinary Complications
    Interventions:   Procedure: assessment of therapy complications;   Procedure: quality-of-life assessment
    Sponsors:   National Cancer Institute (NCI);   Children's Cancer and Leukaemia Group
    Recruiting - verified June 2009

  • Condition:   Optic Nerve Diseases
    Intervention:   Drug: Zyvox - linezolid
    Sponsor:   Pfizer
    Recruiting - verified January 2014

  • Conditions:   Nervous System Malformations;   Arthropathy, Neurogenic;   Urticaria;   Papilledema
    Intervention:  
    Sponsors:   National Institutes of Health Clinical Center (CC);   National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
    Recruiting - verified July 2013

  • Conditions:   Autosomal Recessive Polycystic Kidney Disease;   Congenital Hepatic Fibrosis;   Caroli's Disease;   Polycystic Kidney Disease;   Joubert Syndrome;   Cerebro-Oculo-Renal Syndromes;   COACH Syndrome;   Senior-Loken Syndrome;   Dekaban-Arima Syndrome;   Cogan Oculomotor Apraxia;   Nephronophthisis;   Bardet-Biedl Syndrome;   Alstrom Syndrome;   Oral-Facial-Digital Syndrome
    Intervention:  
    Sponsors:   National Institutes of Health Clinical Center (CC);   National Human Genome Research Institute (NHGRI)
    Recruiting - verified January 2014


PaidClinicalTrials.orgPaidClinicalTrials.org